The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: The GenePD study

Authors

• Jeanne C. Latourelle, Boston University
• Mei Sun, Harvard University
• Mark F. Lew, University of Southern California
• Oksana Suchowersky, University of Calgary
• Christine Klein, Medical University of LuebeckFollow
• Lawrence I. Golbe, University of Medicine and Dentistry of New JerseyFollow
• Margery H. Mark, University of Medicine and Dentistry of New JerseyFollow
• John H. Growdon, Harvard UniversityFollow
• G Frederick Wooten, University of Virginia Health System
• Ray L. Watts, University of Alabama - Birmingham
• Mark Guttman, University of Toronto
• Brad A. Racette, Washington University School of Medicine in St. Louis
• Joel S. Perlmutter, Washington University School of Medicine in St. Louis
• Anwar Ahmed, Barrow Neurological Institute
• Holly A. Shill, Sun Health Research Institute
• Carlos Singer, University of Miami
• Stefano Goldwurm, Instituti Clinici di Perfezionamento
• Gianni Pezzoli, Instituti Clinici di Perfezionamento
• Michela Zini, Instituti Clinici di Perfezionamento
• Marie H. Saint-Hilaire, Boston University
• Audrey E. Hendricks, Boston University
• Sally Williamson, Boston University
• Michael W. Nagle, Boston University
• Jemma B. Wilk, Boston University
• Tiffany Massood, Boston University
• Karen W. Huskey, Boston University
• Jason M. Laramie, Boston University
• Anita L. DeStefano, Boston University
• Kenneth B. Baker, Cleveland Clinic Foundation
• Ilia Itin, Cleveland Clinic Foundation
• Irene Litvan, University of Louisville
• Garth Nicholson, University of Sydney
• Alastair Corbett, University of Sydney
• Martha Nance, Park Nicollet Clinic
• Edward Drasby, Port City Neurology
• Stuart Isaacson, Parkinson's Disease and Movement Disorder Center of Boca Raton
• David J. Burn, Newcastle University
• Patrick F. Chinnery, Newcastle University
• Peter P. Pramstaller, General Regional Hospital Bolzano
• Jomana Al-hinti, University of Arkansas - Medical Sciences
• Anette T. Moller, Aarhus University
• Karen Ostergaard, Aarhus University
• Scott J. Sherman, University of Arizona
• Richard Roxburgh, Auckland City Hospital
• Barry Snow, Auckland City Hospital
• John T. Slevin, University of Kentucky
• Franca Cambi, University of Kentucky
• James F. Gusella, Harvard University
• Richard H. Myers, Boston University

Journal

BMC Medicine

Publication Date

2008

Volume

6

Inclusive Pages

32

Document Type

Open Access Publication

Rights and Permissions

BMC Medicine 2008, 6:32 http://www.biomedcentral.com/1741-7015/6/32 © 2008 Latourelle et al; licensee BioMed Central Ltd.

Recommended Citation

Latourelle, Jeanne C.; Sun, Mei; Lew, Mark F.; Suchowersky, Oksana; Klein, Christine; Golbe, Lawrence I.; Mark, Margery H.; Growdon, John H.; Wooten, G Frederick; Watts, Ray L.; Guttman, Mark; Racette, Brad A.; Perlmutter, Joel S.; Ahmed, Anwar; Shill, Holly A.; Singer, Carlos; Goldwurm, Stefano; Pezzoli, Gianni; Zini, Michela; Saint-Hilaire, Marie H.; Hendricks, Audrey E.; Williamson, Sally; Nagle, Michael W.; Wilk, Jemma B.; Massood, Tiffany; Huskey, Karen W.; Laramie, Jason M.; DeStefano, Anita L.; Baker, Kenneth B.; Itin, Ilia; Litvan, Irene; Nicholson, Garth; Corbett, Alastair; Nance, Martha; Drasby, Edward; Isaacson, Stuart; Burn, David J.; Chinnery, Patrick F.; Pramstaller, Peter P.; Al-hinti, Jomana; Moller, Anette T.; Ostergaard, Karen; Sherman, Scott J.; Roxburgh, Richard; Snow, Barry; Slevin, John T.; Cambi, Franca; Gusella, James F.; and Myers, Richard H., "The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson's disease: The GenePD study." BMC Medicine. 6, 32. (2008).
https://digitalcommons.wustl.edu/open_access_pubs/278